What is the recommended weight-based dose of Promethazine (promethazine) for a pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Promethazine DM Weight-Based Dosing in Pediatrics

Critical Safety Warning

Promethazine is contraindicated in children under 2 years of age due to fatal respiratory depression risk, and weight-based dosing for nausea/vomiting is 0.5 mg per pound (approximately 1.1 mg/kg) with doses of 12.5-25 mg repeated every 4-6 hours as needed. 1


Age Restrictions and Black Box Warning

  • Promethazine is absolutely contraindicated in children under 2 years of age due to FDA black box warning regarding fatal respiratory depression 2, 1
  • This contraindication applies to all formulations and indications 1
  • The respiratory depression risk is particularly concerning when combined with other sedating medications 3

Weight-Based Dosing for Children ≥2 Years

For Nausea and Vomiting

  • The standard weight-based dose is 0.5 mg per pound of body weight (approximately 1.1 mg/kg) 1
  • Typical dosing range: 12.5-25 mg per dose 1
  • Dosing interval: Every 4-6 hours as necessary 1
  • Dose should be adjusted based on age, weight, and severity of condition 1

For Motion Sickness

  • 12.5-25 mg twice daily 1
  • Initial dose should be given 30-60 minutes before travel 1
  • Repeat dose 8-12 hours later if necessary 1

For Allergy

  • 6.25-12.5 mg three times daily, or single 25 mg dose at bedtime 1
  • After initiation, adjust to smallest effective dose 1

For Sedation

  • 12.5-25 mg at bedtime for nighttime sedation 1
  • For preoperative use: 0.5 mg per pound of body weight in combination with appropriately reduced narcotic/barbiturate doses 1

Critical Monitoring Requirements

Respiratory Depression Risk

  • Frequent monitoring is essential, particularly in the first 30 minutes after administration 3
  • One case series documented respiratory arrest within 30 minutes at doses as low as 0.07 ml/kg of combination products containing promethazine 3
  • Respiratory rates as low as 12-20 per minute were observed in patients developing respiratory depression 3

Drug Interactions

  • Extreme caution when combining with other sedating medications (opioids, barbiturates, benzodiazepines) 3
  • Combination products (meperidine-promethazine-chlorpromazine) have documented severe adverse effects including respiratory arrest 3
  • Appropriately reduce doses of concomitant narcotics or barbiturates when using promethazine 1

Route of Administration Considerations

  • Oral route is preferred when tolerated 1
  • Rectal suppositories are an alternative when oral medication cannot be tolerated 1
  • Parenteral administration should be reserved for situations where oral/rectal routes are not feasible 1

Key Clinical Pitfalls

  • Do not use age-based dosing alone—weight-based calculation (0.5 mg/lb or ~1.1 mg/kg) is more accurate 1
  • Never exceed recommended doses even in older/larger children 1
  • Avoid in children with respiratory compromise or those receiving other respiratory depressants 2, 3
  • Do not use for vomiting of unknown etiology in children and adolescents 1
  • Long duration of action requires extended observation periods, particularly important for infants in car safety seats due to re-sedation risk 2

Practical Dosing Algorithm

  1. Verify age ≥2 years (absolute contraindication if younger) 1
  2. Calculate weight in pounds × 0.5 mg = dose per administration 1
  3. Round to nearest available strength: 12.5 mg or 25 mg 1
  4. Administer every 4-6 hours as needed (not to exceed this frequency) 1
  5. Monitor respiratory rate closely for first 30-60 minutes 3
  6. Titrate to lowest effective dose after initial response 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.